2m 2m 2m 2m 2m 2m 2m
Amphastar Pharma (AMPH)
NASDAQ
$18.06-$0.39 (-2.14%)
Price as of Jun 03, 2026 4:57 PM EDT- $831.2MMarket Cap
- -29.07%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Amphastar Pharma (AMPH)
$18.06-$0.39 (-2.14%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 732.0M +13.59% | 644.4M +29.14% | 499.0M +13.98% | |
Cost of Revenue | 363.8M +1.60% | 358.1M +22.11% | 293.3M +17.25% | 250.1M +5.08% | |
Gross Profit | 356.1M -4.76% | 373.9M +6.47% | 351.1M +41.09% | 248.9M +24.59% | |
Sales and Marketing Expense | 43.9M +16.09% | 37.8M +31.02% | 28.9M +34.01% | 21.5M +23.13% | |
Research and Development Expense | -85.8M +16.14% | -73.9M +0.23% | -73.7M -1.38% | -74.8M +22.71% | |
Depreciation and Amortization Expense | 25.0M +1.34% | 24.7M +92.66% | 12.8M +803.52% | 1.4M +10.08% | |
Total Operating Expenses | 215.7M +28.03% | 168.4M +9.28% | 154.1M +9.03% | 141.4M +8.86% | |
Operating Profit | 140.4M -31.65% | 205.4M +4.28% | 197.0M +83.25% | 107.5M +53.82% | |
Interest Income | 8.7M -18.22% | 10.6M +94.39% | 5.5M +313.25% | 1.3M +119.80% | |
Interest Expense | -8.9M 0.00% | -8.9M -67.23% | -27.2M +1,371.18% | -1.8M +108.59% | |
Interest Income and Expense and Net | -221,000 -112.91% | 1.7M +107.89% | -21.7M +4,033.14% | -525,000 +84.86% | |
Total Nonoperating Income and Expense | -16.8M +7.18% | -15.7M -38.91% | -25.6M -399.99% | 8.5M -40.06% | |
Income before Taxes | 123.6M -34.85% | 189.8M +10.74% | 171.4M +47.67% | 116.0M +37.91% | |
Income Taxes | 25.5M -13.96% | 29.7M -6.79% | 31.8M +35.59% | 23.5M +13.80% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 98.1M -38.51% | 159.5M +15.98% | 137.5M +50.51% | 91.4M +47.12% | |
Net Income from Continuing Operations Applicable to Common | 123.6M -34.85% | 189.8M +10.74% | 171.4M +47.67% | 116.0M +37.91% | |
Basic EPS and Net Income | 2.10 -36.17% | 3.29 +15.44% | 2.85 +51.60% | 1.88 +44.62% | |
Diluted EPS and Net Income | 2.03 -33.66% | 3.06 +17.69% | 2.60 +49.43% | 1.74 +39.20% | |
Basic Weighted Average Shares | 46.7M -3.48% | 48.4M +0.34% | 48.3M -0.59% | 48.6M +1.62% | |
Diluted Weighted Average Shares | 48.2M -7.38% | 52.1M -1.78% | 53.0M +1.09% | 52.4M +5.31% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 170.2M +12.25% | 151.6M +5.07% | 144.3M -7.56% | 156.1M +23.54% | |
Short-Term Investments | 112.6M +60.82% | 70.0M -37.75% | 112.5M +472.16% | 19.7M +90.54% | |
Cash and Cash Equivalents and Short-Term Investments | 282.8M +27.60% | 221.6M -13.69% | 256.8M +46.11% | 175.8M +28.60% | |
Total Current Assets | 636.0M +19.09% | 534.1M +9.08% | 489.6M +29.41% | 378.3M +18.92% | |
Accumulated Depreciation | 306.3M +12.77% | 271.6M +10.72% | 245.3M +11.48% | 220.0M +10.22% | |
Property and Plant and Equipment and Net | 310.6M +4.45% | 297.3M +5.16% | 282.7M +18.67% | 238.3M -2.45% | |
Total Long-Term Assets | 31.1M +19.79% | 26.0M +0.32% | 25.9M +24.23% | 20.9M +25.15% | |
Total Assets | 1.6B +3.29% | 1.6B +4.27% | 1.5B +103.90% | 742.0M +10.49% | |
Income Taxes Payable | 6.2M -62.91% | 16.6M +112.57% | 7.8M -34.51% | 11.9M -26.05% | |
Total Short-Term Debt | 1.6M +601.28% | 234,000 -46.33% | 436,000 -85.69% | 3.0M +38.33% | |
Total Current Liabilities | 158.2M -8.98% | 173.8M -22.91% | 225.4M +137.62% | 94.9M -8.62% | |
Total Long-Term Debt | 608.7M +1.18% | 601.6M +2.04% | 589.6M +709.43% | 72.8M -2.59% | |
Total Long-Term Liabilities | 30.0M +43.13% | 20.9M -7.80% | 22.7M +55.98% | 14.6M -6.95% | |
Total Liabilities | 840.5M -0.55% | 845.2M -3.24% | 873.5M +309.46% | 213.3M -5.61% | |
Retained Earnings | 666.9M +17.25% | 568.8M +38.98% | 409.3M +50.62% | 271.7M +50.68% | |
Total Stockholders Equity | 788.8M +7.72% | 732.3M +14.53% | 639.4M +20.95% | 528.7M +18.66% | |
Total Shares Outstanding | 45.6M -4.14% | 47.6M -0.94% | 48.1M -0.09% | 48.1M +0.83% | |
Cash Flow | |||||
Cash from Operating Activities | 156.1M -26.84% | 213.4M +16.28% | 183.5M +105.76% | 89.2M -8.99% | |
Capital Expenditures | 34.9M -15.01% | 41.0M +7.53% | 38.2M +58.80% | 24.0M -12.46% | |
Cash from Investing Activities | -70.3M -43.70% | -124.9M -80.75% | -649.1M +1,880.40% | -32.8M +14.32% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -67.4M -16.71% | -81.0M -117.83% | 454.1M +1,817.51% | -26.4M -28.58% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 51.08% -6.26% | 54.49% +9.25% | 49.87% +9.31% | |
Operating Margin | N/A N/A | 28.06% -8.20% | 30.57% +41.90% | 21.54% +34.94% | |
Return on Assets | 6.12% -40.74% | 10.32% -15.38% | 12.20% -5.65% | 12.93% +35.59% | |
Return on Equity | 12.90% -44.55% | 23.26% -1.24% | 23.55% +25.53% | 18.76% +28.04% | |
Revenue Growth | -100.00% -835.85% | 13.59% -53.36% | 29.14% +108.38% | 13.98% -44.36% | |
Current Ratio | 4.02 +30.84% | 3.07 +41.50% | 2.17 -45.54% | 3.99 +30.14% | |
Cash Ratio | 1.08 +23.32% | 0.87 +36.29% | 0.64 -61.09% | 1.65 +35.19% | |
Debt-to-Equity Ratio | 0.77 -5.85% | 0.82 -10.92% | 0.92 +543.00% | 0.14 -16.96% | |
Debt-to-Assets Ratio | 0.37 -1.81% | 0.38 -2.18% | 0.39 +281.23% | 0.10 -10.73% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow